Literature DB >> 24486184

Trypanosoma cruzi infection results in an increase in intracellular cholesterol.

Christopher Johndrow1, Randin Nelson2, Herbert Tanowitz3, Louis M Weiss3, Fnu Nagajyothi4.   

Abstract

Chagasic cardiomyopathy caused by Trypanosoma cruzi is a major health concern in Latin America and among immigrant populations in non-endemic areas. T. cruzi has a high affinity for host lipoproteins and uses the low density lipoprotein receptor (LDLr) for invasion. Herein, we report that T. cruzi infection is associated with an accumulation of LDL and cholesterol in tissues in both acute and chronic murine Chagas disease. Similar findings were observed in tissue samples from a human case of Chagasic cardiomyopathy. T. cruzi infection of cultured cells displayed increased invasion with increasing cholesterol levels in the medium. Studies of infected host cells demonstrated alterations in their cholesterol regulation. T. cruzi invasion/infection via LDLr appears to be involved in changes in intracellular cholesterol homeostasis. The observed changes in intracellular lipids and associated oxidative stress due to these elevated lipids may contribute to the development of Chagasic cardiomyopathy.
Copyright © 2014 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Chagas disease; Cholesterol; Invasion; LDL; Pathogenesis; Trypanosoma cruzi

Mesh:

Substances:

Year:  2014        PMID: 24486184      PMCID: PMC3999293          DOI: 10.1016/j.micinf.2014.01.001

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  33 in total

Review 1.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.

Authors:  Jay D Horton; Joseph L Goldstein; Michael S Brown
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 2.  Pathophysiological insights into the cardiomyopathy of Chagas' disease.

Authors:  S A Morris; H B Tanowitz; M Wittner; J P Bilezikian
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

3.  Trypanosoma cruzi: phosphatidylinositol 3-kinase and protein kinase B activation is associated with parasite invasion.

Authors:  S E Wilkowsky; M A Barbieri; P Stahl; E L Isola
Journal:  Exp Cell Res       Date:  2001-04-01       Impact factor: 3.905

4.  Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity.

Authors:  F S Machado; G A Martins; J C Aliberti; F L Mestriner; F Q Cunha; J S Silva
Journal:  Circulation       Date:  2000-12-12       Impact factor: 29.690

5.  High- and low-density lipoproteins enhance infection of Trypanosoma cruzi in vitro.

Authors:  R P Prioli; I Rosenberg; M E Pereira
Journal:  Mol Biochem Parasitol       Date:  1990-01-15       Impact factor: 1.759

6.  Seroprevalence of Trypanosoma cruzi in raccoons from South Carolina and Georgia.

Authors:  Michael J Yabsley; Gayle Pittman Noblet
Journal:  J Wildl Dis       Date:  2002-01       Impact factor: 1.535

7.  Host metabolism regulates intracellular growth of Trypanosoma cruzi.

Authors:  Kacey L Caradonna; Juan C Engel; David Jacobi; Chih-Hao Lee; Barbara A Burleigh
Journal:  Cell Host Microbe       Date:  2013-01-16       Impact factor: 21.023

8.  Role for interleukin-1 beta in Trypanosoma cruzi-induced cardiomyocyte hypertrophy.

Authors:  Christine A Petersen; Barbara A Burleigh
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  A novel cholesterol stain reveals early neuronal cholesterol accumulation in the Niemann-Pick type C1 mouse brain.

Authors:  Patrick C Reid; Naomi Sakashita; Shigeki Sugii; Yoshiko Ohno-Iwashita; Yukiko Shimada; William F Hickey; Ta-Yuan Chang
Journal:  J Lipid Res       Date:  2004-01-01       Impact factor: 5.922

10.  Chagas disease in a domestic transmission cycle, southern Texas, USA.

Authors:  Charles B Beard; Greg Pye; Frank J Steurer; Ray Rodriguez; Richard Campman; A Townsend Peterson; Janine Ramsey; Robert A Wirtz; Laura E Robinson
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

View more
  22 in total

1.  Antagonistic effect of atorvastatin on high fat diet induced survival during acute Chagas disease.

Authors:  Dazhi Zhao; Kezia Lizardo; Min Hui Cui; Kamalakar Ambadipudi; Jose Lora; Linda A Jelicks; Jyothi F Nagajyothi
Journal:  Microbes Infect       Date:  2016-07-12       Impact factor: 2.700

2.  Diet regulates liver autophagy differentially in murine acute Trypanosoma cruzi infection.

Authors:  Kezia Lizardo; Vanessa Almonte; Calvin Law; Janeesh Plakkal Aiyyappan; Min-Hui Cui; Jyothi F Nagajyothi
Journal:  Parasitol Res       Date:  2016-12-16       Impact factor: 2.289

3.  Opportunities and challenges in chronic Chagas cardiomyopathy.

Authors:  George A Mensah; Kristin M Burns; Emmanuel K Peprah; Uchechukwu K A Sampson; Michael M Engelgau
Journal:  Glob Heart       Date:  2015-09

4.  The brighter (and evolutionarily older) face of the metabolic syndrome: evidence from Trypanosoma cruzi infection in CD-1 mice.

Authors:  Daniel J Eden; Syed Faizan Mehdi; Michelle Bravo; Mohammad M Wiese; Joanna Stein; Vanessa Almonte; Dazhi Zhao; Jesse Roth; Fnu Nagajyothi; Wunnie Brima; Irwin Kurland; Jeffrey E Pessin; Tomas Zima; Herbert B Tanowitz; Louis M Weiss
Journal:  Diabetes Metab Res Rev       Date:  2015-03-06       Impact factor: 4.876

5.  Modulation of Cholesterol Pathways in Human Macrophages Infected by Clinical Isolates of Leishmania infantum.

Authors:  José Ignacio Manzano; Ana Perea-Martínez; Raquel García-Hernández; Eduardo Andrés-León; Laura C Terrón-Camero; José Antonio Poveda; Francisco Gamarro
Journal:  Front Cell Infect Microbiol       Date:  2022-04-29       Impact factor: 6.073

6.  High fat diet aggravates cardiomyopathy in murine chronic Chagas disease.

Authors:  Kezia Lizardo; Janeesh Plakkal Ayyappan; Min-Hui Cui; Rashmi Balasubramanya; Linda A Jelicks; Jyothi F Nagajyothi
Journal:  Microbes Infect       Date:  2018-07-31       Impact factor: 2.700

Review 7.  Developments in the management of Chagas cardiomyopathy.

Authors:  Herbert B Tanowitz; Fabiana S Machado; David C Spray; Joel M Friedman; Oren S Weiss; Jose N Lora; Jyothi Nagajyothi; Diego N Moraes; Nisha Jain Garg; Maria Carmo P Nunes; Antonio Luiz P Ribeiro
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-23

Review 8.  Adipose Tissue: A Safe Haven for Parasites?

Authors:  Herbert B Tanowitz; Philipp E Scherer; Maria M Mota; Luisa M Figueiredo
Journal:  Trends Parasitol       Date:  2016-12-19

9.  Trypanosoma cruzi infection is a potent risk factor for non-alcoholic steatohepatitis enhancing local and systemic inflammation associated with strong oxidative stress and metabolic disorders.

Authors:  Luisina I Onofrio; Alfredo R Arocena; Augusto F Paroli; María E Cabalén; Marta C Andrada; Roxana C Cano; Susana Gea
Journal:  PLoS Negl Trop Dis       Date:  2015-02-10

Review 10.  Trypanosoma cruzi infection and host lipid metabolism.

Authors:  Qianqian Miao; Momar Ndao
Journal:  Mediators Inflamm       Date:  2014-09-03       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.